Acadian Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Acadian Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75K	Buy	+282	New	+$65.9K	﹤0.01%	1806
2026 Q1	–	Sell	-5,291	Closed	-$1.13M	–	2018
2025 Q4	$1.13M	Sell	5,291 -6,948	-57%	-$1.43M	﹤0.01%	1089
2025 Q3	$2.43M	Buy	+12,239	New	+$2.28M	﹤0.01%	846
2025 Q2	–	Sell	-411	Closed	-$64K	–	1653
2025 Q1	$64K	Sell	411 -71,648	-99%	-$10.2M	﹤0.01%	1405
2024 Q4	$9.91M	Sell	72,059 -48,835	-40%	-$6.42M	0.03%	360
2024 Q3	$18M	Sell	120,894 -21,271	-15%	-$2.87M	0.06%	247
2024 Q2	$19.4M	Sell	142,165 -108,327	-43%	-$14.7M	0.06%	243
2024 Q1	$37.8M	Buy	250,492 +234,446	+1,461%	+$33.5M	0.13%	149
2023 Q4	$2.02M	Buy	+16,046	New	+$1.6M	0.01%	667

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Acadian Asset Management's ASND Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 282 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in ASND as recently as Q4 2025.

Acadian Asset Management first reported a position in ASND in Q4 2023 and has held it in 9 quarters since. The position peaked at $37.8M in Q1 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Acadian Asset Management held 282 shares of Ascendis Pharma A/S worth $75K as of Q2 2026.
Ascendis Pharma A/S was a new Acadian Asset Management position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1806 holding.
Acadian Asset Management first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 9 quarters since.
Acadian Asset Management's Ascendis Pharma A/S position peaked at $37.8M in Q1 2024.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.